DiaMedica Therapeutics
(NASDAQ:DMAC)
$1.68
-0.10[-5.62%]
At close: Aug 9
$1.60
-0.0800[-4.76%]
After Hours: 6:18PM EDT
Day High/Low1.66 - 1.79
52 Week High/Low1.15 - 3.94
Open / Close1.78 / 1.68
Float / Outstanding26M / 26.4M
Vol / Avg.32.1K / 137.9K
Mkt Cap44.4M
P/E-
50d Avg. Price1.88
Div / Yield-
Payout Ratio-
EPS-0.13
Total Float26M

DiaMedica Therapeutics (NASDAQ:DMAC), Quotes and News Summary

DiaMedica Therapeutics (NASDAQ: DMAC)

Day High/Low1.66 - 1.79
52 Week High/Low1.15 - 3.94
Open / Close1.78 / 1.68
Float / Outstanding26M / 26.4M
Vol / Avg.32.1K / 137.9K
Mkt Cap44.4M
P/E-
50d Avg. Price1.88
Div / Yield-
Payout Ratio-
EPS-0.13
Total Float26M
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-09
REV
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-10
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

DiaMedica Therapeutics Questions & Answers

Q
How do I buy DiaMedica Therapeutics (DMAC) stock?
A

You can purchase shares of DiaMedica Therapeutics (NASDAQ: DMAC) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are DiaMedica Therapeutics's (DMAC) competitors?
A

There are no as such competitors for DiaMedica Therapeutics.

Q
What is the target price for DiaMedica Therapeutics (DMAC) stock?
A

The latest price target for DiaMedica Therapeutics (NASDAQ: DMAC) was reported by Lake Street on Thursday, July 7, 2022. The analyst firm set a price target for 8.00 expecting DMAC to rise to within 12 months (a possible 376.19% upside). 3 analyst firms have reported ratings in the last year.

Q
Current Stock Price for DiaMedica Therapeutics (DMAC)?
A

The stock price for DiaMedica Therapeutics (NASDAQ: DMAC) is $1.68 last updated August 9, 2022, 8:00 PM UTC.

Q
Does DiaMedica Therapeutics (DMAC) pay a dividend?
A

There are no upcoming dividends for DiaMedica Therapeutics.

Q
When is DiaMedica Therapeutics (NASDAQ:DMAC) reporting earnings?
A

DiaMedica Therapeutics’s Q3 earnings are confirmed for Wednesday, November 9, 2022.

Q
Is DiaMedica Therapeutics (DMAC) going to split?
A

There is no upcoming split for DiaMedica Therapeutics.

Q
What sector and industry does DiaMedica Therapeutics (DMAC) operate in?
A

DiaMedica Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.